IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Royalty Pharma Sub-Manager, LLCDeep ValueConcentrated trader

CIK: 0002081668 | New York, NY

Q1 2026 vs Q2 2026 ComparisonProfile

Filing History

QuarterForm TypeHoldingsValueFiledSEC
Q2 2026Amended
13F-HR/A4$241.9M2026-08-14SEC ↗
Q1 2026Amended
13F-HR/A4$172.8M2026-05-14SEC ↗
Q4 2025Amended
13F-HR/A4$171.3M2026-04-01SEC ↗